A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Arog Pharmaceuticals, Inc.
Start Date
January 16, 2017
End Date
November 30, 2020
Administered By
Duke Cancer Institute
Awarded By
Arog Pharmaceuticals, Inc.
Start Date
January 16, 2017
End Date
November 30, 2020